Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-01 Purchase | 2021-06-02 4:37 pm | Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 490 | $2.93 | $1,436 | 1,016,098 (Indirect) | View |
| 2021-05-25 Purchase | 2021-05-28 6:49 pm | Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 602 | $2.4876 | $1,498 | 2,031,031 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Shabahang Shahrokh Chief Innovation Officer | 7,053 | $0 | 7,053 (Direct) | View |
| 2021-07-22 Option Award | 2021-11-12 9:50 pm | N/A N/A | Aditxt Inc. | ADTX | Shabahang Shahrokh Chief Innovation Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2021-03-17 Exercise | 2021-03-22 4:16 pm | 2018-03-17 2021-03-17 | Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 18,750 | $0 | 1,015,006 (Indirect) | View |
| 2021-03-17 Exercise | 2021-03-22 4:16 pm | N/A N/A | Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 18,750 | $4 | 1,015,006 (Indirect) | View |
| 2020-11-02 Option Award | 2020-11-04 9:20 pm | N/A 2030-11-02 | ADiTx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 110,000 | $0 | 110,000 (Direct) | View |
| 2020-07-24 Exercise | 2020-08-03 8:27 pm | 2020-07-02 2025-06-29 | ADiTx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 47,222 | $11.25 | 996,256 (Indirect) | View |
Ownership | 2020-07-09 9:17 pm | N/A N/A | ADiTx Therapeutics Inc. | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 0 | $0 | 1,235,159 (Indirect) | View |